Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humacyte HAV in PAD femoro-popliteal bypass
NCT02887859Phase 2Completed
- Sponsor
- Humacyte
- Start
- Dec 2016
- Primary completion
- Dec 2020
- Modality
- Device-based Delivery, Tissue Cells, Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of acellular tissue engineered vessel in peripheral artery disease (PAD), sponsored by Humacyte. Started Dec 2016; status: completed.
02
Drugs
acellular tissue engineered vessel
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT02887859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02887859.